Company — InterMune
Products for antibiotic-resistant infectious diseases, including Esbriet for idiopathic pulmonary fibrosis. (Acquired by Roche)
Products for antibiotic-resistant infectious diseases, including Esbriet for idiopathic pulmonary fibrosis. (Acquired by Roche)